45.85
price up icon4.63%   2.03
after-market After Hours: 45.85
loading

Akero Therapeutics Inc Stock (AKRO) Latest News

pulisher
06:32 AM

Akero Therapeutics CEO Andrew Cheng sells $1.25 million in stock - Investing.com

06:32 AM
pulisher
03:40 AM

Proficio Capital Partners LLC Acquires Shares of 11,490 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

03:40 AM
pulisher
Mar 11, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Timothy Rolph Sells 12,500 Shares - MarketBeat

Mar 11, 2025
pulisher
Mar 11, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Rating of "Buy" from Analysts - MarketBeat

Mar 11, 2025
pulisher
Mar 11, 2025

Q1 EPS Estimate for Akero Therapeutics Boosted by Analyst - MarketBeat

Mar 11, 2025
pulisher
Mar 09, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 50,000 Shares of Stock - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Sells $48,090.00 in Stock - MarketBeat

Mar 09, 2025
pulisher
Mar 08, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stake Decreased by Y Intercept Hong Kong Ltd - MarketBeat

Mar 08, 2025
pulisher
Mar 08, 2025

Trading (AKRO) With Integrated Risk Controls - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

Akero therapeutics chief scientific officer sells $556,590 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Akero therapeutics chief scientific officer sells $556,590 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Update - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Issues Optimistic Estimate for AKRO Earnings - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Akero Therapeutics (NASDAQ:AKRO) Given New $75.00 Price Target at HC Wainwright - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

Akero Therapeutics senior VP sells $48,090 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Boston Pharma Plays Catch Up To Akero, 89bio In MASH - Citeline News & Insights

Mar 06, 2025
pulisher
Mar 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 06, 2025
pulisher
Mar 05, 2025

Akero Therapeutics senior VP sells $48,090 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Akero Therapeutics Executives Sell Shares - TradingView

Mar 05, 2025
pulisher
Mar 05, 2025

Akero therapeutics COO Jonathan Young sells $2.24 million in stock By Investing.com - Investing.com UK

Mar 05, 2025
pulisher
Mar 05, 2025

Y Intercept Hong Kong Ltd Has $249,000 Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Up 32.0% in February - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Akero Therapeutics (NASDAQ:AKRO) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Investors to Inquire about Securities Investigation - Markets Insider

Mar 04, 2025
pulisher
Mar 04, 2025

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Akero Therapeutics stock target raised to $75 by H.C. Wainwright - Investing.com India

Mar 03, 2025
pulisher
Mar 02, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stake Lifted by Rhumbline Advisers - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Why Akero Therapeutics, Inc. (AKRO) is Skyrocketing So Far in 2025 - MSN

Mar 02, 2025
pulisher
Mar 02, 2025

Akero Therapeutics (AKRO) to Release Earnings on Friday - MarketBeat

Mar 02, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

Akero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Akero Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

3 Mid-Caps Worth Watching Closely in March - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Akero Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

Akero Therapeutics Q4 Loss Unchanged -February 28, 2025 at 07:27 am EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Earnings Flash (AKRO) Akero Therapeutics Posts Q4 Total Operating Expenses $78M - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Earnings Flash (AKRO) Akero Therapeutics Posts Q4 Loss $-0.99 Per Share, vs. FactSet Est of $-1.14 - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - The Bakersfield Californian

Feb 28, 2025
pulisher
Feb 28, 2025

Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Feb 28, 2025
pulisher
Feb 28, 2025

Can Akero's Breakthrough Cirrhosis Reversal Results Reshape MASH Treatment Landscape? - StockTitan

Feb 28, 2025
pulisher
Feb 28, 2025

IMMINENT AKRO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Akero Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - accessnewswire.com

Feb 28, 2025
pulisher
Feb 27, 2025

Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts? - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Akero Therapeutics (AKRO) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Madrigal’s Rezdiffra Continues Its Solid Launch - Scrip

Feb 26, 2025
pulisher
Feb 26, 2025

Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant - MSN

Feb 26, 2025
pulisher
Feb 25, 2025

10 Best Performing Mid Cap Stocks to Buy According to Analysts - Insider Monkey

Feb 25, 2025
pulisher
Feb 25, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 10,000 Shares of Stock - MarketBeat

Feb 25, 2025
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):